Milan: Pharmanutra moves up

(Teleborsa) - Marked growth for the pharmaceutical company specialized in the development of nutraceutical supplements and medical devices as it records a +3.05% improvement on previous levels.

The weekly analysis of the security and the FTSE Italia Mid Cap shows Pharmanutra losing relative strength against the index.

Pharmanutra's technical status shows signs of decline with support listed at 47.8 Euros, while on the upside resistance can be identified at 49.85. In the next session we could witness a further downswing with a likely target of 46.6.

These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)

(Teleborsa) 05-16-2024 12:30 PM